Contemporary Clinical Trials Communications • December 2022
Contemporary Clinical Trials Communications • December 2022
Journal of Perinatology • July 2022
Frontiers in Pharmacology • March 2022
Journal of Perinatology • January 2022
Clinical Pharmacokinetics • June 2021
Antimicrobial Agents and Chemotherapy • June 2021
The Pediatric Infectious Disease Journal • June 2021
Pediatrics • May 2021
Abdel-Rahman SM, Paul IM, Hornik C, Sullivan JE, Wade K, Delmore P, Sharma G, Benjamin DK, Zimmerman KO
The Best Pharmaceuticals for Children Act (BPCA) incentivizes the study of on-patent medicines in children and mandates that the NIH sponsor research on off-patent drugs important to pediatric therapeutics. Failing to enroll cohorts that reflect the pediatric population at large restricts the generalizability of such studies. This investigation evaluates racial and ethnic minority representation among participants enrolled in BPCA-sponsored studies. This study revealed no evidence of racial and ethnic bias in enrollment for pediatric studies conducted with funding from BPCA, fulfilling the legislation’s expectation to ensure adequate representation of all children.
The Journal of Clinical Pharmacology • March 2021